The drug-based pipeline against restenosis

Author： Keller Pierre-Frédéric Ibrahim Reda Tardif Jean-Claude

ISSN： 1472-8214

Source： Expert Opinion on Emerging Drugs, Vol.10, Iss.1, 2005-02, pp. : 67-86

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Restenosis Treatments Using Nanoparticle-based Drug Delivery Systems

Current Pharmaceutical Design, Vol. 19, Iss. 35, 2013-10 ,pp. : 6330-6339

Bentham Science Publishers

Access to resources Recommend Favorite

Broadening the clinical use of platinum drug–based chemotherapy with new analogues

By Kelland Lloyd

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 7, 2007-06 ,pp. : 1009-1021

Informa Healthcare

Access to resources Recommend Favorite

Stent-based delivery of decoy oligodeoxynucleotides against activator protein-1 binding site decreased restenosis in rabbits

By Lin Kaimin Zhao Ziwen Chen Lianglong

Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol. 68, Iss. 8, 2013-08 ,pp. : 661-667

Govi-Verlag

Access to resources Recommend Favorite

An editorial in Nature argues the case for drug-based cognitive enhancement for both the healthy and the unwell.

Inpharma, Vol. 1, Iss. 1621, 2008-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Paclitaxel-eluting stent safe, effective against restenosis

Inpharma, Vol. 1, Iss. 1421, 2004-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite